nieuws 2024

« BACK

Pharmacology



Results 1 - 5 of 5.


Environment - Pharmacology - 26.06.2024
Fewer measurements required to determine level of pharmaceutical residues in wastewater due to new model
It is becoming increasingly obvious that pharmaceutical residues in wastewater are damaging to the environment, making it imperative that wastewater is tested for such residues. However, wastewater measurements are expensive and time-consuming. A new model developed by Radboud University-affiliated environmental scientist Caterina Zillien can be used to determine the amount of pharmaceutical residues in wastewater - and their exact origin - every bit as precisely as actual measurements.

Health - Pharmacology - 01.05.2024
Patients with rheumatoid arthritis have unique and complex autoantibody patterns
Patients with rheumatoid arthritis have unique and complex autoantibody patterns
Research challenges therapeutic approaches and ideas about disease backgrounds Patients with rheumatoid arthritis (RA) all'have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity of these antibodies using powerful lab tools capable of analysing our immune system at molecular levels.

Health - Pharmacology - 08.04.2024
Better understanding of how breast cancer works
Better understanding of how breast cancer works
In her research into the response of breast cancer to the hormone estrogen, PhD candidate Stacey Joosten studied not only hormone-sensitive breast cancer in postmenopausal women but also in men and in women before the menopause. The aim was to gain an even better understanding of how this type of breast cancer works.

Pharmacology - Economics - 26.03.2024
How to prevent social desirability bias in surveys
Marketing researcher Rik Pieters has developed, together with colleagues from other universities, a new, indirect questioning technique to improve the chance that people answer truthfully. The technique can be used, for instance, in conducting surveys or in making policies. Chances are that people tend to give socially desirable answers to direct survey questions on sensitive subjects, like watching porn, smoking during pregnancy, theft in the supermarket or illegal acquisition of prescription drugs.

Pharmacology - Health - 28.02.2024
Many new oncology drugs approved in the EU lack proof of added benefit
Many new oncology drugs approved in the EU lack proof of added benefit
Many cancer drugs recently approved by the European Medicines Agency (EMA) lack clear proof of added benefit. This is particularly the case for drugs that are granted via special processes, intended to accelerate the approval of promising treatments. A research team from Utrecht University draws this conclusion today in the scientific journal The BMJ .